Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

CVS Health : profit beats as pharmacy margins rise

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/02/2017 | 06:06pm CEST
People walk outside a CVS store in Pasadena

CVS Health Corp (>> CVS Health Corp) reported a bigger-than-expected quarterly profit as higher margins in its pharmacy business helped offset the loss of major contracts last year.

CVS Health Corp (>> CVS Health Corp) reported a bigger-than-expected quarterly profit as higher margins in its pharmacy business helped offset the loss of major contracts last year.

Same-store prescription volumes fell 460 basis points in the first quarter due to the loss of contracts to fill prescriptions for Tricare, a U.S. Department of Defense health care program, and for customers of pharmacy benefits manager Prime Therapeutics, to rival Walgreens Boots Alliance Inc (>> Walgreens Boots Alliance Inc).

However, higher generic drug dispensing rate and a cut back on promotions at the front-end of the store lifted gross margin in the pharmacy business by about 35 basis points to 29.4 percent.

Front-end same-store sales fell 4.9 percent in the first three months ended March 31. The company sells beauty products, snacks and over-the-counter drugs at the front-end of its nearly 9,700 stores.

Front-end same-store sales slipped for the fourth straight quarter and the company has been investing to turn around sales by improving the store layout and product assortment.

CVS reiterated its 2017 profit forecast and estimated second-quarter adjusted earnings largely below analysts' average estimate of $1.33 per share.

The company's shares were down 2 percent at $80.23 in morning trading on Tuesday. Through Monday's close, they had gained 5.4 percent since Walgreens reported a surprise drop in sales last month.

Revenue in CVS's bigger pharmacy services business rose 8.5 percent to $31.2 billion as claims increased across its network and on strong demand for its specialty pharmacy service.

The specialty pharmacy service provides expensive drugs to people with chronic conditions such as rheumatoid arthritis.

Net income attributable to CVS fell to $952 million, or 92 cents per share, in the first quarter, from $1.15 billion, or $1.04 per share, a year earlier.

Interest expenses declined 11 percent to $252 million, while the company also got $19 million in tax benefits from the adoption of new accounting guidance for share-based compensation.

Excluding items, the company earned $1.17 per share.

Revenue rose 3 percent to $44.51 billion.

Analysts on average had expected earnings of $1.10 per share on revenue of $44.20 billion, according to Thomson Reuters I/B/E/S.

(Reporting by Sruthi Ramakrishnan in Bengaluru; Editing by Saumyadeb Chakrabarty and Sriraj Kalluvila)

Stocks treated in this article : CVS Health Corp, Walgreens Boots Alliance Inc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
10:54a CVS HEALTH : SXU Featured in CVS Health Report
06/27 CVS HEALTH : Today's Research Reports on Stocks to Watch: Rite Aid and CVS Healt..
06/23 CVS HEALTH : appeals to the City Council in its effort to move into Laguna Drug ..
06/21 CVS HEALTH : Points of Light Recognizes CVS Health As One Of The 50 Most Communi..
06/21 CVS : Experts Discuss How Medicaid Innovations Reduce Costs and Increase Access ..
06/21 CVS HEALTH : Monroe County's tax battle with CVS not over
06/19 CVS HEALTH : Today's Research Reports on Stocks to Watch: CVS Health and Walgree..
06/16 CVS : By the Numbers: Real-World Impact of Rising Drug Costs
06/15 CVS HEALTH : Pharmacy Now Using Time Delay Safes in Ohio for Controlled Substanc..
06/14 CVS HEALTH : Medicaid as a Driver of Care Innovation
More news
Sector news : Drug Retailers - NEC
06/22DJWALGREENS BOOTS ALLIANCE : Theranos, Walgreens to Settle -- WSJ
06/21DJWALGREENS BOOTS ALLIANCE : Theranos, Walgreens Reach Deal to Settle Lawsuit--Upd..
06/21 STADA ARZNEIMITTEL : Low acceptances leave Stada bid down to the wire
06/21DJWALGREENS BOOTS ALLIANCE : Theranos, Walgreens Reach Deal to Settle Lawsuit
06/20 U.S. Supreme Court again limits where companies can be sued
More sector news : Drug Retailers - NEC
News from SeekingAlpha
06/27 WALGREENS/CVS : Good Free-Cash-Flow, But Now In Amazon's Sights
06/26 How To Beat XLP For The Active Investor
06/26 Smart Beta Dividend Growth Stocks
06/26 Sifting Through The Retail Wreck
06/23 The MnM Portfolio, June 2017 Supplement - How Amazon-Proof Is The Portfolio?
Advertisement
Financials ($)
Sales 2017 184 164 M
EBIT 2017 10 168 M
Net income 2017 5 376 M
Debt 2017 24 614 M
Yield 2017 2,45%
P/E ratio 2017 15,60
P/E ratio 2018 13,84
EV / Sales 2017 0,58x
EV / Sales 2018 0,55x
Capitalization 82 003 M
More Financials
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 87,1 $
Spread / Average Target 8,2%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH2.00%82 003
WALGREENS BOOTS ALLIAN..-6.65%83 514
EXPRESS SCRIPTS HOLDIN..-6.06%38 792
MCKESSON CORPORATION18.68%35 248
CARDINAL HEALTH INC10.12%25 034
AMERISOURCEBERGEN CORP..22.18%20 860
More Results